journal article·2025-08-29Open access

Electrospun Biomaterials for Scarless Acne Wound Healing: Advances and Prospects

Jiahui Chen, Liping Zhou, Zhongci Hang, Xiaochun Bian, Tong Huo, Bing Peng, Haohao Li, Yongqiang Wen, Hongwu Du

Abstract

Acne vulgaris is a chronic disease that occurs in the pilosebaceous units and ranks eighth in the global prevalence of all diseases. In its severe forms such as pustules, cysts, and nodules, acne can lead to permanent scarring and post-inflammatory hyperpigmentation, which are often difficult to reverse in the short term and significantly affect patients’ psychological well-being and social interactions. Although a variety of pharmacological treatments are available, including retinoids, antibiotics, anti-androgens, benzoyl peroxide, and corticosteroids, the high recurrence rate and limited efficacy in scar prevention highlight the urgent need for innovative therapeutic strategies. Electrospinning technology has recently gained attention for fabricating nanofibrous patches with high porosity, biocompatibility, and biodegradability. These patches can offer antibacterial activity, absorb exudates, and provide mechanical protection, making them promising platforms for acne wound care. This review first outlines the pathophysiology of acne and the biological mechanisms underlying scar formation. We then present an overview of electrospinning techniques, commonly used polymers, and recent advancements in the field. Finally, we explore the potential of electrospun nanofibers loaded with mesenchymal stem cells or exosomes as next-generation therapeutic systems aimed at promoting scarless acne healing.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Dermatologic Treatments and Research · Acne and Rosacea Treatments and Effects · Skin Protection and Aging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Beijing Key Laboratory for Bioengineering and Sensing Technology, Daxing Research Institute, School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083, China

Shandong Laboratory of Advanced Materials and Green Manufacturing at Yantai, Yantai Zhongke Research Institute of Advanced Materials and Green Chemical Engineering, Yantai 264006, China

Funding

National Natural Science Foundation of China · Beijing Natural Science Foundation Youth Project · Interdisciplinary Research Project for Young Teachers of USTB, Fundamental Research Funds for the Central Universities · Science Fund of Shandong Laboratory of Advanced Materials and Green Manufacturing (Yantai)

References (100+)

Show source-provided references
1. TREM2 macrophages induced by human lipids drive inflammation in acne lesions10.1126/sciimmunol.abo2787 ↗
2. Management of acne: Canadian clinical practice guideline10.1503/cmaj.140665 ↗
3. Adult acne versus adolescent acne: A narrative review with a focus on epidemiology to treatment10.1016/j.abd.2022.01.006 ↗
4. Acne vulgaris10.1038/nrdp.2015.29 ↗
5. The global burden of skin disease in 2010: An analysis of the prevalence and impact of skin conditions10.1038/jid.2013.446 ↗
6. Cumulative mental health consequences of acne: 23-year follow-up in a general population birth cohort study10.1111/bjd.13786 ↗
7. Acne vulgaris: Role of the immune system10.1111/ijd.15415 ↗
8. Targeting TGF-β signal transduction for fibrosis and cancer therapy10.1186/s12943-022-01569-x ↗
9. Recent applications on biopolymers electrospinning: Strategies, challenges and way forwards
10. Fibrous hydrogels by electrospinning: Novel platforms for biomedical applications10.1177/20417314231191881 ↗
11. Bioinspired Janus All-Natural Electrospinning Membranes with Directional Water Transport as Ecofriendly Dry Facial Masks10.1021/acssuschemeng.2c02094 ↗
12. Electrospun fibers for the treatment of skin diseases10.1016/j.jconrel.2023.10.009 ↗
13. Control of Surface Wrinkles on Shape Memory PLA/PPDO Micro-nanofibers and Their Applications in Drug Release and Anti-scarring10.1007/s42765-022-00249-1 ↗
14. Therapeutic complex-loaded polyvinyl alcohol nanofibers enriched with lemon juice extract for controlled drug release in acne management10.1016/j.matchemphys.2025.131079 ↗
15. Hao, Y., Lin, X., Liu, W., Jiang, T., Zhang, X., Yang, S., Huang, Y., Lai, W., Fu, C., and Zhang, Z. (2025). Development of nanofiber facial mask inspired by the multi-function of dried ginger (Zingiberis Rhizoma) essential oil. Sci. Rep., 15.10.1038/s41598-024-84571-1 ↗
16. Effects of microenvironment and biological behavior on the paracrine function of stem cells10.1016/j.gendis.2023.03.013 ↗
17. Elhabal, S.F., Abdelmonem, R., El Nashar, R.M., Elrefai, M.F.M., Hamdan, A.M.E., Safwat, N.A., Shoela, M.S., Hassan, F.E., Rizk, A., and Kabil, S.L. (2024). Enhanced Antibacterial Activity of Clindamycin Using Molecularly Imprinted Polymer Nanoparticles Loaded with Polyurethane Nanofibrous Scaffolds for the Treatment of Acne Vulgaris. Pharmaceutics, 16.10.3390/pharmaceutics16070947 ↗
18. Relationship between acne vulgaris and cosmetic usage in Sri Lankan urban adolescent females10.1111/jocd.12431 ↗
19. Acne and diet: A review10.1111/ijd.15862 ↗
20. What’s new in the physiopathology of acne?10.1111/bjd.13634 ↗
21. What is new in the pathophysiology of acne, an overview10.1111/jdv.14374 ↗
22. Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis10.1007/s13555-021-00552-6 ↗
23. The Skin Microbiome: A New Actor in Inflammatory Acne10.1007/s40257-020-00531-1 ↗
24. Decrease in Diversity of Propionibacterium acnes Phylotypes in Patients with Severe Acne on the Back10.2340/00015555-2847 ↗
25. Cutibacterium acnes phylotypes diversity loss: A trigger for skin inflammatory process10.1111/jdv.15795 ↗
26. Hyperandrogenism in adolescent girls: Relationship with the somatotrophic axis10.1515/jpem-2016-0340 ↗
27. Sex hormones and acne: State of the art
28. Apo B-48 gene expression and low-density lipoprotein as a factor for increased insulin resistance and severity of acne10.1016/j.gene.2023.147703 ↗
29. Effect of insulin-like growth factor-1 deficiency or administration on the occurrence of acne10.1111/j.1468-3083.2010.03896.x ↗
30. Anti-acne drugs in phase 1 and 2 clinical trials10.1080/13543784.2017.1337745 ↗
31. c-MYC-induced sebaceous gland differentiation is controlled by an androgen receptor/p53 axis10.1016/j.celrep.2013.01.013 ↗
32. Androgens modulate keratinocyte differentiation indirectly through enhancing growth factor production from dermal fibroblasts10.1016/j.jdermsci.2019.01.007 ↗
33. Su, Z., Zhang, Y., Cao, J., Sun, Y., Cai, Y., Zhang, B., He, L., Zhang, Z., Xie, J., and Meng, Q. (2023). Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist. J. Nanobiotechnol., 21.10.1186/s12951-023-01812-7 ↗
34. Effect of oral isotretinoin on the nucleo-cytoplasmic distribution of FoxO1 and FoxO3 proteins in sebaceous glands of patients with acne vulgaris10.1111/exd.13787 ↗
35. Mdm2 phosphorylation by Akt regulates the p53 response to oxidative stress to promote cell proliferation and tumorigenesis10.1073/pnas.2003193118 ↗
36. Regulation of mTORC1 and its impact on gene expression at a glance
37. The role of follicular hyperkeratinization in acne10.1080/095466300750163645 ↗
38. New understandings of the pathogenesis of acne10.1016/0190-9622(95)90416-6 ↗
39. Acne. Current pathophysiologic considerations
40. Interleukin-1 alpha blockade prevents hyperkeratosis in an model of lamellar ichthyosis10.1093/hmg/ddq145 ↗
41. Comedogenesis: Some aetiological, clinical and therapeutic strategies10.1159/000067825 ↗
42. Skin Immune Landscape: Inside and Outside the Organism10.1155/2017/5095293 ↗
43. The skin microbiome10.1038/nrmicro2537 ↗
44. O’Neill, A., and Gallo, R. (2018). Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris. Microbiome, 6.10.1186/s40168-018-0558-5 ↗
45. Jończyk-Matysiak, E., Weber-Dąbrowska, B., Żaczek, M., Międzybrodzki, R., Letkiewicz, S., Łusiak-Szelchowska, M., and Górski, A. (2017). Propionibacterium acnesProspects of Phage Application in the Treatment of Acne Caused by. Front. Microbiol., 8.10.3389/fmicb.2017.00164 ↗
46. Propionibacterium acnes strain populations in the human skin microbiome associated with acne10.1038/jid.2013.21 ↗
47. Barnard, E., Shi, B., Kang, D., Craft, N., and Li, H. (2016). The balance of metagenomic elements shapes the skin microbiome in acne and health. Sci. Rep., 6.10.1038/srep39491 ↗
48. Cutibacterium acnesCommensal induce epidermal lipid synthesis important for skin barrier function10.1126/sciadv.adg6262 ↗
49. Acne, the Skin Microbiome, and Antibiotic Treatment10.1007/s40257-018-00417-3 ↗
50. Skin microbiome and acne vulgaris: Staphylococcus, a new actor in acne10.1111/exd.13296 ↗
51. Gannesen, A., Zdorovenko, E., Botchkova, E., Hardouin, J., Massier, S., Kopitsyn, D., Gorbachevskii, M., Kadykova, A., Shashkov, A., and Zhurina, M. (2019). Composition of the Biofilm Matrix of Cutibacterium acnes Acneic Strain RT5. Front. Microbiol., 10.10.3389/fmicb.2019.01284 ↗
52. Comparative analyses of biofilm formation among different Cutibacterium acnes isolates10.1016/j.ijmm.2018.09.005 ↗
53. Acne: Transient Arrest in the Homeostatic Host-Microbiota Dialog?10.1016/j.it.2019.08.006 ↗
54. Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL10.1046/j.1365-2133.2004.05762.x ↗
55. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: Host response but not bacterial species is the determinant factor of the disease10.1016/j.jdermsci.2009.02.015 ↗
56. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components10.1016/S1074-7613(00)80119-3 ↗
57. Inhibition of HDAC8 and HDAC9 by microbial short-chain fatty acids breaks immune tolerance of the epidermis to TLR ligands10.1126/sciimmunol.aah4609 ↗
58. Inflammasomes: Mechanism of assembly, regulation and signalling10.1038/nri.2016.58 ↗
59. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes10.1016/j.cell.2014.02.008 ↗
60. IL-1β drives inflammatory responses to propionibacterium acnes in vitro and in vivo10.1038/jid.2013.438 ↗
61. Adipose-derived stem cells attenuate acne-related inflammation via suppression of NLRP3 inflammasome10.1186/s13287-022-03007-7 ↗
62. Recent advances in understanding inflammatory acne: Deciphering the relationship between Cutibacterium acnes and Th17 inflammatory pathway10.1111/jdv.18794 ↗
63. Propionibacterium acnes and the Th1/Th17 Axis, Implications in Acne Pathogenesis and Treatment10.4103/ijd.IJD_483_16 ↗
64. Cell-free extracts of Propionibacterium acnes stimulate cytokine production through activation of p38 MAPK and Toll-like receptor in SZ95 sebocytes10.1016/j.lfs.2015.07.028 ↗
65. Lee, H., and Jang, Y. (2018). Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids. Int. J. Mol. Sci., 19.10.3390/ijms19030711 ↗
66. Expression of inflammatory and fibrogenetic markers in acne hypertrophic scar formation: Focusing on role of TGF-β and IGF-1R10.1007/s00403-018-1856-2 ↗
67. Biology of interleukin-1010.1016/j.cytogfr.2010.09.002 ↗
68. Reduced decorin, fibromodulin, and transforming growth factor-β3 in deep dermis leads to hypertrophic scarring10.1097/BCR.0b013e3182335980 ↗
69. Potential cellular and molecular causes of hypertrophic scar formation10.1016/j.burns.2008.06.020 ↗
70. Acne Scar Treatment: A Multimodality Approach Tailored to Scar Type10.1097/DSS.0000000000000746 ↗
71. Atrophic acne scar: A process from altered metabolism of elastic fibres and collagen fibres based on transforming growth factor-β1 signalling10.1111/bjd.17851 ↗
72. A systematic review of comparative clinical trials on the efficacy, safety, and patient satisfaction of ablative and non-ablative laser therapies for atrophic, hypertrophic, and keloid scars10.1007/s10103-025-04519-3 ↗
73. Intralesional injection of vitamin D3, platelet rich plasma versus their combination in treatment of keloid: A clinical, radiological and immunohistochemical study10.1007/s00403-025-04244-5 ↗
74. Fractional carbon dioxide laser treatment of hypertrophic scar clinical and histopathological evaluation10.1007/s10103-025-04371-5 ↗
75. The effectiveness of fractional laser-assisted photodynamic therapy utilizing methylene blue for the treatment of keloids10.1007/s00403-025-04058-5 ↗
76. Observational retrospective study evaluating the effects of oral isotretinoin in keloids and hypertrophic scars10.1111/ijd.13317 ↗
77. Pulsed Dye Laser Therapy in the Treatment of Warts: A Review of the Literature10.1097/DSS.0000000000001023 ↗
78. CO Laser Treatment for Regional Cutaneous Malignant Melanoma Metastases10.1097/DSS.0000000000000251 ↗
79. The effect of CO2 laser treatment on skin tissue10.1111/jocd.12142 ↗
80. A clinical study of carbon dioxide lattice laser-assisted or microneedle-assisted 5-aminolevulinic acid-based photodynamic therapy for the treatment of hypertrophic acne scars10.1111/phpp.12716 ↗
81. Safety and efficacy of CO dot matrix laser combined with platelet-rich plasma on depressed scar after acne vulgaris and influencing factors of its repair effect: A retrospective analysis10.1111/jocd.15501 ↗
82. Dai, R., Cao, Y.Y., Su, Y.P., and Cai, S.Q. (2023). Comparison of 1064-nm Nd:YAG picosecond laser using fractional micro-lens array vs. ablative fractional 2940-nm Er:YAG laser for the treatment of atrophic acne scar in Asians: A 20-week prospective, randomized, split-face, controlled pilot study. Front. Med., 10.10.3389/fmed.2023.1248831 ↗
83. Hawwas, A., Mohamed, H., Sayedahmed, O., and Elsaie, M. (2023). Topical timolol maleate 0.5% after fractional carbon dioxide laser versus fractional carbon dioxide laser alone in treatment of acne scars: Split face comparative study. Sci. Rep., 13.10.1038/s41598-023-36398-5 ↗
84. Effect and Safety Analysis of PRP and Yifu Combined with Ultrapulsed CO Lattice Laser in Patients with Sunken Acne Scar
85. The Efficacy and Safety of Fractional 1064 nm Nd:YAG Picosecond Laser Combined with Intense Pulsed Light in the Treatment of Atrophic Acne Scar: A Split-Face Study10.1002/lsm.23428 ↗
86. Fractional ablative CO laser and oral isotretinoin—A prospective randomized controlled split-face trial comparing concurrent versus delayed laser treatment for acne scars10.1002/lsm.23713 ↗
87. Efficacy and safety comparison between 1927 nm thulium laser and 2940 nm Er:YAG laser in the treatment of facial atrophic acne scarring: A prospective, simultaneous spilt-face clinical trial10.1007/s10103-021-03465-0 ↗
88. Garg, K., and Bowlin, G. (2011). Electrospinning jets and nanofibrous structures. Biomicrofluidics, 5.10.1063/1.3567097 ↗
89. Valorization of Municipal Biowaste into Electrospun Poly(3-hydroxybutyrate-3-hydroxyvalerate) Biopapers for Food Packaging Applications10.1021/acsabm.0c00698 ↗
90. Electrospinning of native cellulose from nonvolatile solvent system10.1016/j.polymer.2008.04.046 ↗
91. Fadil, F., Affandi, N.D.N., Misnon, M.I., Bonnia, N.N., Harun, A.M., and Alam, M.K. (2021). Review on Electrospun Nanofiber-Applied Products. Polymers, 13.10.3390/polym13132087 ↗
92. Electrospinning of polymeric nanofibers for drug delivery applications10.1016/j.jconrel.2014.04.018 ↗
93. Orientated and diameter-controlled fibrous scaffolds fabricated using the centrifugal electrospinning technique for stimulating the behaviours of fibroblast cells10.1177/1528083720988127 ↗
94. Coaxial electrospun membranes with thermal energy storage and shape memory functions for simultaneous thermal/moisture management in personal cooling textiles10.1016/j.eurpolymj.2020.110245 ↗
95. High speed electrospinning for scaled-up production of amorphous solid dispersion of itraconazole10.1016/j.ijpharm.2015.01.025 ↗
96. Evolving Trends in Nanofibers for Topical Delivery of Therapeutics in Skin Disorders10.1021/acsomega.3c00924 ↗
97. Unfolding the electrospinning potential of biopolymers for preparation of nano fi bers10.1016/j.jddst.2020.101604 ↗
98. Insight on updates in polysaccharides for ocular drug delivery10.1016/j.carbpol.2022.120014 ↗
99. Electrospinning process: Versatile preparation method for biodegradable and natural polymers and biocomposite systems applied in tissue engineering and drug delivery10.1016/j.apsusc.2014.01.098 ↗
100. Icariin-loaded electrospun PCL/gelatin sub-microfiber mat for preventing epidural adhesions after laminectomy10.2147/IJN.S169427 ↗